관절내 보충 요법 시장 : 용량별, 관절염 유형별, 최종사용자별, 지역별

Global Viscosupplementation Market is estimated to be valued at USD 4.15 Bn in 2025 and is expected to reach USD 7.11 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.0% from 2025 to 2032.

Figure. Viscosupplementation Market Share (%), By Region 2025

Viscosupplementation is an orthopedic treatment method used to manage osteoarthritis knee pain. It involves injecting hyaluronic acid, also known as hyaluronan, into the knee joint. Hyaluronic acid acts as a lubricant and shock absorber in the joints. It replenishes levels in the joint that diminish with osteoarthritis. This helps reduce pain and improve mobility by supplementing the viscous nature of the synovial fluid in knees affected by osteoarthritis. Viscosupplementation therapy is a non-surgical treatment option that provides relief from knee osteoarthritis symptoms for extended periods of time.

Market Dynamics:

The global viscosupplementation market is driven by the rising geriatric population which is more prone to develop osteoarthritis and the associated joint pains. As per estimates, over 330 million people currently suffer from osteoarthritis globally. This is projected to increase substantially in the coming years. Moreover, growing awareness about advanced non-invasive treatment alternatives and favorable reimbursement policies for viscosupplementation procedures are boosting the market. However, the market growth can be restrained by the preference for alternative treatment methods like dietary supplements and limitations in the efficacy and duration of pain relief provided by hyaluronic acid injections. The integration of 3D printing and robotic technologies to develop patient-specific hyaluronic acid formulations provides lucrative opportunities in this market.

Key Features of the Study:

• This report provides in-depth analysis of the global viscosupplementation market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global viscosupplementation market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study includes Anika Therapeutics Inc., Seikagaku Corporation, Ferring Pharmaceuticals, Bioventus, Fidia Farmaceutici S.P.A., Mylan N.V., Sanofi S.A., OrthogenRx, Teva Pharmaceutical Industries Ltd, Johnson & Johnson., F. Hoffmann-La Roche AG, Zimmer Biomet, Aptissen, Wellchem Pharmaceuticals Pte Ltd., Juniper Biologics, and Ono Pharmaceutical Co., Ltd.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global viscosupplementation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global viscosupplementation market.

Market Segmentation

• Dosage:
  • Single Injection
  • Three Injection
  • Five Injection
• Arthritis Type:
  • Osteoarthritis
  • Rheumatoid Arthritis
• End User:
  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Others
• Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
• Company Profiles:
  • Anika Therapeutics Inc.
  • Seikagaku Corporation
  • Ferring Pharmaceuticals
  • Bioventus
  • Fidia Farmaceutici S.P.A.
  • Mylan N.V.
  • Sanofi S.A.
  • OrthogenRx
  • Teva Pharmaceutical Industries Ltd
  • Johnson & Johnson.
  • Hoffmann-La Roche AG
  • Zimmer Biomet
  • Aptissen
  • Wellchem Pharmaceuticals Pte Ltd.
  • Juniper Biologics
  • Ono Pharmaceutical Co., Ltd

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Dosage
  • Market Snapshot, By Arthritis Type
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Recent Developments
• Acquisitions and Partnerships Scenario
• Technology Overview
• Regulatory Scenario
• PEST Analysis

4. Global Viscosupplementation Market- Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Impact on Supply and Demand
• COVID-19 Impact on the Market

5. Global Viscosupplementation Market, By Dosage, 2020 - 2032, (US$ Billion)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Single Injection
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Three Injection
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Five Injection
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

6. Global Viscosupplementation Market, By Arthritis Type, 2020 - 2032, (US$ Billion)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Osteoarthritis
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Rheumatoid Arthritis
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

7. Global Viscosupplementation Market, By End User, 2020 - 2032, (US$ Billion)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Hospitals
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Specialty Clinics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Ambulatory Surgical Centers
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

8. Global Viscosupplementation Market, By Region, 2020 - 2032, (US$ Billion)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Regions, 2020-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Arthritis Type, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
  • U.S.
  • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Arthritis Type, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Arthritis Type, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Arthritis Type, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Arthritis Type, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
  • GCC
  • Israel
  • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Arthritis Type, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (US$ Billion)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

• Anika Therapeutics Inc
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Seikagaku Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Ferring Pharmaceuticals
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Bioventus
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Fidia Farmaceutici S.P.A.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Mylan N.V.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Sanofi S.A.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• ORTHOGENRX
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Teva Pharmaceutical Industries Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Johnson & Johnson
• F. Hoffmann-La Roche AG
• Zimmer Biomet
• Aptissen
• Wellchem Pharmaceuticals Pte Ltd.
• Juniper Biologics
• Ono Pharmaceutical Co., Ltd

10. Analyst View

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact